Novo Nordisk’s $2B deal for obesity drug a strategic game-changer for US pharmaceutical market
Danish pharmaceutical company Novo Nordisk — best known for its blockbuster weight-loss drugs Ozempic and Wegovy — has signed ...
‘There's a huge percentage of the US population that isn't getting access to these medications’: Novo Nordisk makes game-changing $2 billion deal for new obesity d…
Danish pharmaceutical company Novo Nordisk — best known for its blockbuster weight-loss drugs Ozempic and Wegovy — has signed ...
Home Health Care News19h
Home-Based Pediatric Care A Leap For Patients, A Struggle For Providers
I wrote a story on pediatric private-duty nurses that has become one of our most-read articles so far in 2025 and elicited reader engagement.